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Abstract: The beneficial effects of exercise training (EX) on cardiac pathology are well recognized.
Previously, we found that the effects of EX on cardiac dysfunction in mice critically depend on
the underlying etiology. EX exerted beneficial effects after myocardial infarction (MI); however,
cardiac pathology following pressure overload produced by transverse aortic constriction (TAC) was
aggravated by EX. In the presented study, we investigated whether the contrasting effects of EX on
cardiac dysfunction can be explained by an etiology-specific response of endothelial nitric oxide (NO)
synthase (eNOS) to EX, which divergently affects the balance between nitric oxide and superoxide.
For this purpose, mice were exposed to eight weeks of voluntary wheel running or sedentary housing
(SED), immediately after sham, MI, or TAC surgery. Left ventricular (LV) function was assessed
using echocardiography and hemodynamic measurements. EX ameliorated LV dysfunction and
remodeling after MI, but not following TAC, in which EX even aggravated fibrosis. Strikingly, EX
attenuated superoxide levels after MI, but exacerbated NOS-dependent superoxide levels following
TAC. Similarly, elevated eNOS S-glutathionylation and eNOS monomerization, which were observed
in both MI and TAC, were corrected by EX in MI, but aggravated by EX after TAC. Additionally,
EX reduced antioxidant activity in TAC, while it was maintained following EX in MI. In conclusion,
the present study shows that EX mitigates cardiac dysfunction after MI, likely by attenuating eNOS
uncoupling-mediated oxidative stress, whereas EX tends to aggravate cardiac dysfunction following
TAC, likely due to exacerbating eNOS-mediated oxidative stress.
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1. Introduction
During the last decade, heart failure (HF) has developed into a major public-health burden
worldwide [1,2]. Consequently, the development of novel strategies for the treatment of HF becomes
increasingly important. In addition to optimal pharmacotherapy, physical exercise training (EX)
is increasingly implemented in the rehabilitation process of HF patients. The beneficial effects of
EX on exercise capacity and cardiovascular performance are well established [3], and translate into
improvements in quality of life, as well as reductions in HF-related hospitalizations and mortality [3–7].
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An important player in the many protective effects of exercise is endothelial nitric oxide (NO)
synthase (eNOS) [8–10]. In the presence of its co-factors, eNOS transfers electrons from reduced
nicotinamide adenine dinucleotide phosphate (NADPH), via the flavin adenine dinucleotide and
flavin mononucleotide to the heme site, where electrons are utilized to reduce and activate oxygen,
and to oxidize L-arginine to L-citrulline and NO [11]. EX increases shear stress and mechanical
stretch, which stimulate eNOS activity and increase NO production [9,12]. NO has various beneficial
effects on cardiovascular function, including vasodilation, the inhibition of platelet aggregation and
adhesion, the inhibition of leukocytes and vascular inflammation, the stimulation of angiogenesis,
the proliferation of vascular smooth muscle cells, and the activation of endothelial progenitor cells [13].
In addition to the stimulation of eNOS, EX beneficially influences the cardiac nitroso–redox balance
by activating reactive oxygen species (ROS) scavenger enzymes such as superoxide dismutases
(SODs) [14,15]. Accordingly, we and others have demonstrated that EX improves survival and
attenuates LV dysfunction, oxidative stress, and fibrosis in a mouse model of myocardial infarction
(MI) [16–19], and have additionally demonstrated that full eNOS expression is required for these
beneficial EX effects after MI [20].
In contrast to experimental [18] and clinical [21] evidence demonstrating beneficial effects of EX
after MI, patients with obstruction of the left ventricular (LV) outflow tract, are advised to perform only
mild exercise or to refrain from physical strain [22,23]. In line with these guidelines, we previously
found that EX failed to exert a beneficial effect, and even tended to aggravated cardiac dysfunction
and remodeling in mice suffering from chronic pressure overload produced by transverse aortic
constriction (TAC) [24].
The mechanism underlying these contrasting effects of EX in different cardiac pathologies remains
unresolved, but could involve divergent effects of EX on eNOS. Under pathological conditions,
eNOS can uncouple and convert from an NO− to a superoxide (O2−)-producing enzyme. Several
mechanisms have been proposed to induce eNOS uncoupling, including eNOS monomerization [13]
and S-glutathionylation of eNOS [25]. Uncoupled eNOS is still capable of transferring electrons,
but the electrons are diverted to oxygen rather than to L-arginine, resulting in the production of O2−,
and subsequently, further eNOS uncoupling [13].
In light of these considerations, we hypothesized that EX influences the nitroso–redox balance and
eNOS in a pathology-specific manner so that EX can either stimulate NO or eNOS-mediated superoxide
production, depending on the underlying cardiac pathology. To test our hypothesis, we investigated
how EX affects eNOS and the nitroso–redox balance in two distinct but clinically highly relevant
cardiac pathologies by studying the effects of EX in mice with either MI or TAC.
2. Results
2.1. Exercise and Survival
All mice in the EX groups began running voluntarily on the first day after surgery (Figure 1A,B).
The total eight-week distance was lower in TACEX (237 ± 57 km) and MIEX (245 ± 47 km) than in
sham (SH)EX mice (435± 60 km; Figure 1B). In the sedentary housing (SED) group, MISED and TACSED
had survival rates of 62% and 63%, respectively, while EX did not affect mortality in any of the groups
(Figure 1C).
2.2. LV Remodeling and Dysfunction
MI and TAC both increased relative LV weight and lumen diameter (Figures 1D and 2A,B),
decreased LV systolic dysfunction, as indicated by LV dP/dtmax and fractional shortening (FS),
as well as early (LV dP/dtmin) and late LV diastolic dysfunction (LV end diastolic pressure (LVEDP))
(Figure 2C–F,I). Furthermore, in both MI and TAC, cardiac backward failure was evidenced by an
increase in relative right ventricular (RV) weight (Figure 2G), while marked LV fibrosis was observed
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in TAC (Figure 2H,J). EX improved LV remodeling and dysfunction after MI. In contrast, EX failed to
ameliorate, and even tended to aggravate LV remodeling and dysfunction after TAC (Figure 2).
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Figure 1. Experimental models, daily running distance, and survival. (A) Voluntary wheel running; 
(B) daily running distance of sham (SH), myocardial infarction (MI), and transverse aortic constriction 
(TAC) mice; (C) Kaplan–Meier survival curve for all groups; (D) post-mortem examples of hearts and 
cardiac cross sections of sham mice and mice with an MI or TAC. Total number of animals entering 
the study in voluntary running (EX) and sedentary housing (SED) groups: SHSED (n = 12), SHEX (n = 
22), MISED (n = 21), MIEX (n = 19), TACSED (n = 19), and TACEX (n = 16). * p < 0.05 total running distance 
vs. total running distance of sham mice. 
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Figure 2. Exercise (EX) mitigates cardiac remodeling and dysfunction following myocardial infarction 
(MI), but not after transverse aortic constriction (TAC). (A) Left ventricle (LV) weight (LVW) per tibia 
length (TL); (B) LV end diastolic lumen diameter (LVEDD); (C) maximum rate of rise in LV pressure 
(dP/dtmax); (D) fractional shortening (FS); (E) maximum rate of fall in LV pressure (dP/dtmin); (F) LV 
end diastolic pressure (LVEDP); (G) right ventricle weight (RVW) per TL; (H) collagen content; (I) 
representative LV short axis and M-Mode echo images; (J) representative images of collagen staining. 
* p < 0.05 vs. corresponding sham, † p < 0.05 vs. corresponding sedentary. n = 12 in all groups. 
2.3. Superoxide Production 
Having established that the effects of exercise on LV function and remodeling were etiology-
dependent, we sought to determine the potential role of etiology-dependent superoxide generation 
in the effects of exercise. In LV myocardium of the sedentary groups, MI and TAC both increased 
superoxide generation compared to sham-operated animals (Figure 3A). This increase was abolished 
in MI and markedly reduced in TAC by NOS inhibition with NG-nitro-L-arginine methyl ester (L-
NAME; Figure 3B). Interestingly, EX inhibited superoxide production in MI, but significantly 
increased superoxide levels following TAC (Figure 3A). Similarly, L-NAME-inhibitable, and 
therefore, NOS-dependent superoxide generation was blunted by EX following MI, but markedly 
aggravated by EX following TAC (Figure 3C). These findings suggest a direct functional relation 
between NOS and the contrasting effects of EX in myocardial superoxide production. 
 
Figure 2. Exercise (EX) mitigates cardiac remodeling and dysfunction following myocardial infarction
(MI), but not after transverse aortic constriction (TAC). (A) Left ventricle (LV) weight (LVW) per
tibia length (TL); (B) LV end diastolic lumen diameter (LVEDD); (C) maximum rate of rise in LV
pressure (dP/dtmax); (D) fractional shortening (FS); (E) maximum rate of fall in LV pressure (dP/dtmin);
(F) LV end diastolic pressure (LVEDP); (G) right ventricle weight (RVW) per TL; (H) collagen content;
(I) representative LV short axis and M-Mode echo images; (J) representative images of collagen staining.
* p < 0.05 vs. corresponding sham, † p < 0.05 vs. corresponding sedentary. n = 12 in all groups.
2.3. Superoxide Production
Having established that the effects of exercise on LV function and remodeling were
etiology-dependent, we sought to determine the potential role of etiology-depen ent superoxide
generation in the effects of exercise. In LV myocardium of the sedentary groups, MI and TAC both
increased superoxide generation compared to sham-operated animals (Figure 3A). This increase was
abolished in MI and markedly reduced in TAC by NOS inhibition with NG-nitro-L-arginine methyl
ester (L-NAME; Figure 3B). Interestingly, EX inhibited superoxide production in MI, but significantly
increased superoxide levels following TAC (Figure 3A). Similarly, L-NAME-inhibitable, and therefore,
NOS-dependent superoxide generation was blunted by EX following MI, but markedly aggravated by
EX following TAC (Figure 3C). These findings suggest a direct functional relation between NOS and
the contrasting effects of EX in myocardial superoxide production.
2.4. Total eNOS and Phosphorylated eNOS (p-eNOS) Protein Expression
To investigate whether the divergent effects of EX in MI and TAC could be explained by eNOS
expression or phosphorylation levels, we examined the effect of EX on eNOS protein expression
and eNOS serine (Ser)1177 phosphorylation. There was no difference in total cardiac eNOS protein
expression between sham, MI, and TAC groups either with or without EX (Figure 3D,J). In contrast,
p-eNOS Ser1177 levels were reduced after MI, but were increased after TAC. EX significantly increased
the expression of p-eNOS Ser1177 in sham and MI groups, but did not further change p-eNOS Ser1177
levels in TAC mice (Figure 3E,K).
2.5. eNOS Uncoupling and eNOS S-Glutathionylation
Since eNOS uncoupling is a potential inducer of eNOS-mediated superoxide formation, we
subsequently determined the eNOS monomer–dimer ratio and the level of eNOS S-glutathionylation.
The eNOS monomer–dimer ratio was increased after both MI and TAC, and reduced by EX in MI,
but further elevated by EX in TAC mice (Figure 3F,L).
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(eNOS), and glutathionylation after sham (SH), myocardial infarction (MI), and transverse
aortic constriction (TAC). (A) Lucigenin-enhanced chemiluminescence superoxide production is
expressed as relative light unit (RLU) per second per gram protein; (B) evaluation of superoxide
production with NG-nitro-L-arginine methyl ester (L-NAME), presented as L-NAME-independent
superoxide; (C) subtraction of L-NAME-independent superoxide from total superoxide, presented as
L-NAME-inhibitable superoxide; (D) eNOS protein expression; (E) phosphorylated eNOS (p-eNOS)
serine (Ser)1177 protein expression; (F) eNOS monomer–dimer ratio; (G) oxidized glutathion (GSSG)
and reduced glutathion (GSH) ratio; (H) S-glutathionylation of eNOS; (I) superoxide dismutase
(SOD) activity; (J) representative western blot of eNOS protein expression; (K) representative
western blot of p-eNOS serine (Ser)1177 protein expression; (L) representative eNOS monomer dimer
blot; (I) representative co-immunoprecipitation of eNOS S-glutathionylation with unspecific mouse
immunoglobulin G (IgG) antibody as a negative control. p-eNOS: phosphorylated eNOS; eNOS S-glut:
eNOS S-glutathionylation. * p < 0.05 vs. corresponding sham, † p < 0.05 vs. corresponding sedentary.
n = 3–8 in all groups.
The oxidized glutathione disulfide (GSSG) to reduced glutathione (GSH) ratio was not affected
by MI, but was elevated after TAC. Additionally, the increase in superoxide levels in TACEX
mice was accompanied by a further increase in the GSSG:GSH ratio (Figure 3G). Moreover, while
S-glutathionylation of eNOS was modestly elevated in MI and TAC mice, this increase in eNOS
S-glutathionylation was normalized by EX in MI, but aggravated in exercised TAC mice (Figure 3H,M).
Taken together, eNOS S-glutathionylation and eNOS monomerization data indicate that eNOS
uncoupling is normalized by EX following MI, but aggravated by EX in the presence of TAC.
2.6. Superoxide Dismutase (SOD) Activity
To investigate whether divergent effects of EX on eNOS-mediated superoxide generation
additionally involved altered antioxidant activity, we studied the activity of SOD. Total SOD activity
was not changed after MI or TAC compared to sham-operated animals. Interestingly, EX did not alter
SOD activity in sham and MI groups, but significantly decreased SOD activity in TAC mice (Figure 3I).
Int. J. Mol. Sci. 2018, 19, 1968 6 of 12
3. Discussion
In the presented study, we tested the hypothesis that eNOS-derived NO and superoxide play a
key role in the divergent effects of EX on cardiac remodeling and dysfunction following MI versus
chronic pressure overload produced by TAC. The major findings were that (i) eight weeks of voluntary
EX after MI decreased superoxide production, whereas EX following TAC increased superoxide
production; (ii) these divergent responses were principally explained by EX-induced reduction of
eNOS-mediated myocardial superoxide levels after MI, as opposed to an EX-induced increase in
eNOS-mediated superoxide production in TAC; (iii) accordingly, EX reduced eNOS uncoupling,
evidenced by reductions in myocardial eNOS S-glutathionylation and eNOS monomerization after MI,
whereas EX aggravated TAC-induced eNOS uncoupling evidenced by increased S-glutathionylation
and eNOS monomerization after TAC (Figure 4).
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One of the key components of the beneficial effects of EX in cardiovascular disease is improved
endothelial function through eNOS [12,29]. Accordingly, previous studies from our laboratory showed
that the beneficial effects of EX following MI require full eNOS expression [20]. In line with this
observation, eNOS overexpression was shown to improve cardiac function after MI [30,31]. In the
present study, we found that exercise after MI attenuated eNOS uncoupling, which explains the
reduction of eNOS-dependent superoxide production after EX in MI.
It is known that divergent cardiac pathologies activate distinct pathological signaling pathways
that result in specific disease characteristics [32]. Consequently, measures that prove to be protective
of the diseased heart are not necessarily equally beneficial in all cardiac etiologies. Accordingly,
although the benefit of EX is clearly established in most forms of cardiac disease [7], patients with
moderate-to-severe aortic stenosis are recommended to avoid competitive sports to reduce the risk
of sudden death [22,23]. We recently observed that EX not only failed to ameliorate, but even tended
to aggravate cardiac dysfunction in chronic pressure overload produced by TAC [24]. In the present
study, we found that this lack of benefit from EX in TAC is accompanied by EX-induced worsening of
eNOS uncoupling (evidenced by eNOS S-glutathionylation and eNOS monomerization), as well as
EX-induced reduction of SOD activity, leading to increased eNOS-mediated oxidative stress. Even
though we did not demonstrate a direct causal relationship between elevated ROS and aggravated
cardiac dysfunction following TAC and EX, the data strongly suggest that elevated eNOS-mediated
ROS levels importantly contribute to the worsening of cardiac performance when TAC is combined
with EX. Likely, the fixed stenosis in TAC counteracts an important part of the beneficial effects of eNOS
since it precludes the reduction in LV afterload resulting from eNOS-mediated systemic vasodilation.
Indeed, beneficial effects of EX were described in hypertension, where stimulation of eNOS is able
to reduce cardiac afterload [33,34]. Moreover, the fixed stenosis amplifies the EX-induced increase
in LV systolic pressure, and hence, LV afterload during each exercise bout [35]. A meta-analysis
performed by Haykowsky et al. [36] suggests this may adversely affect the LV response to EX by
showing that dynamic EX, which results in modest increases in LV systolic pressure, had beneficial
effects on ejection fraction in heart-failure patients, whereas static EX, which is known to result in
more marked elevations in LV systolic pressure, failed to improve ejection fraction [11]. Apparently,
the EX-induced increase in LV systolic pressure during EX in TAC exacerbated the TAC-induced
cardiac pathology, and further aggravated detrimental eNOS uncoupling and concomitant oxidative
stress. Treatment of TAC mice with phosphodiesterase type 5 (PDE5) inhibitors was previously shown
to improve cardiac pathological hypertrophy [37]. Therefore, it could be interesting to explore whether
treatment of EX TAC mice with NO donors might mitigate the detrimental effects of exercise and
TAC on eNOS uncoupling and consequent ROS production. However, this should be the topic of
future studies.
Clinical guidelines recommend at least 30 min of physical activity on most, if not all, days of the
week to reduce risk factors for chronic disease [38,39]. In cardiovascular disease patients, EX not only
improves exercise performance and quality of life, but also reduces morbidity and mortality [3,5–7].
Notwithstanding these clear benefits of EX, EX restriction is recommended for patients with aortic
stenosis [22]. However, no beneficial effects of EX restriction were observed in a large cohort study
involving more than 500 patients suffering from congenital aortic stenosis [40]. Thus, the potential
benefits or hazards of EX in patients with aortic stenosis remain under debate, and recommendations
appear to be based on pathophysiological considerations, rather than on hard clinical evidence [7].
Our study shows that, unlike after MI, EX may aggravate cardiac pathology in the presence of an aortic
stenosis because of an etiology-dependent effect of EX on the nitroso–redox balance. We demonstrate
that the balance between cardiac NO and superoxide is differentially affected by EX in diverse etiologies
and pivotal in the mechanisms of both beneficial and detrimental effects of EX.
In conclusion, the presented study demonstrates that the balance between cardiac NO and
superoxide plays a pivotal role in determining both the beneficial and detrimental effects of EX. Thus,
the underlying pathology determines whether eNOS tilts the nitroso–redox balance toward either
Int. J. Mol. Sci. 2018, 19, 1968 8 of 12
a beneficial or a detrimental influence. This observation may be important for therapies aiming to
restore the nitroso–redox balance in patients with heart failure due to different etiologies, and may aid
in improving disease-mechanism-specific interventions.
4. Materials and Methods
All experiments were performed in accordance with and following approval by the Animal
Research Committee of the Erasmus MC University of Rotterdam (27 June 2006 nr: 109-06-12 EUR976).
A total of 99 C57Bl/6 mice 12–20-week-old mice entered the study: sham sedentary (SHSED; n = 12),
sham exercise (SHEX; n = 12), MI sedentary (MISED; n = 21), MI exercise (MIEX; n = 19), TAC sedentary
(TACSED; n = 19), and TAC exercise (TACEX; n = 16). Males and females were equally distributed
between groups.
4.1. Animal Experiments
All mice were sedated with 4% isoflurane, intubated, and connected to a pressure-controlled
ventilator (SAR-830/P; CWE, Ardmore, PA, USA). Anesthesia was maintained using 2.5% isoflurane,
while body temperature was kept at 37 ◦C, and buprenorphine was administered (50 µg/kg;
intraperitoneally (i.p.)) for postsurgical analgesia. Sham, MI, and TAC surgery were performed
as previously described [24,41]. After recovery from surgery, all exercise groups were exposed to
eight weeks of voluntary wheel running (Figure 1B). The timeline of SH, MI, and TAC experiments is
visualized in Figure 5.
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4.2. Cardiac Function and Geometry Measurements
Eight we ks after sham, MI, or TAC surgery, all mice were re-anesthetized and ventilated, and
body temperature as ◦ hile M-mode LV echocardiography was performed using
an Aloka SSD 4000 echo d vice (Aloka; Tokyo, Japan). Following echocardiogra hy, a pressur
cathete (Millar Instrument; Houston, TX, USA) was inserted into the LV via the carotid artery, LV
pres ure (LVP) was measured. LV dP/dtmax and LV dP/dtmi l t si g atLab [24].
Subsequently, the heart was excised and the LV, right ventricle (RV), and lung weight, as well as tibia
length, were measured. LV tis ue was rapidly snap-frozen after extraction, and stored for further
molecular analysis, or embed ed in paraffin for histological analysis. In MI animals, all analyses were
performed in remote, viable, LV myocardium.
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4.3. Histology
Paraffin-embedded LV tissue of six mice per group was serially sectioned (4 µm). Collagen content
was measured after Picrosirius red staining under polarized light, and analyzed with a quantitative
image-analysis system (Clemex Technologies, Longueuil, QC J4G 1T5, Canada).
4.4. Detection of Superoxide Production
Superoxide generation in homogenized snap-frozen LV tissue (4–6 samples per group) was
evaluated by lucigenin-enhanced chemiluminescence using a luminometer (Luminoskan Ascent,
Thermo Fisher Scientific, Waltham, MA, USA)) as previously described [42]. Briefly, LV tissue
was homogenized in Krebs-Hepes buffer, dark-adapted lucigenin (final concentration 5 µM) was
added to the homogenates, and basal chemiluminescence was measured after reaching equilibrium.
Subsequently, NOS-dependent superoxide production was measured by repeating the measurements
after adding the NOS inhibitor, NG-nitro-L-arginine methyl ester (L-NAME; 1 mM), to the homogenates.
Light emission was recorded, and was expressed as relative light units (RLU)/sec/g. Each experiment
was performed in duplicate.
4.5. Total and Phosphorylated eNOS Protein Analysis
Total eNOS and p-eNOS protein levels were determined in LV homogenates as previously
described [43], and normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Novus
Biologicals, Littleton, CO, USA)).
Subsequent to SDS-PAGE, the proteins were transferred to nitrocellulose membranes, and
the blots were probed with primary anti-eNOS (1:500, BD Transduction Laboratory, San Jose, CA,
USA), anti-p-eNOS (1:1000 Cell Signaling, Danvers, MA, USA), anti-GAPDH (1:10,000, Imgenex),
and secondary rabbit anti-mouse immunoglobulin G (IgG) antibody conjugated with horseradish
peroxidase (HRP; 1:1000, Santa Cruz Biotechnology, Dallas, TX, USA). All blots were analyzed using
the Odyssey system (LI-COR, Lincoln, NE 68504, USA).
4.6. Quantification of GSSG and GSH
The oxidized glutathione disulfide (GSSG) to reduced glutathione (GSH) ratio was assessed using
a glutathione assay kit (Cayman Chemical, Ann Arbor, MI, USA). LV tissue was homogenized in cold
2-(N-morpholino) ethanesulfonic acid (MES) buffer, before being centrifuged at 10,000× g for 15 min
at 4 ◦C. Samples were deproteinated using metaphosporic acid and triethanolamine (Sigma-Aldrich,
Saint Lois, MI, USA), and total GSH was immediately measured at 405 nm at five-minute intervals for
30 min. GSSG was measured independently, using 2-vinylpiridine (Sigma-Aldrich).
4.7. eNOS S-Glutathionylation
To determine S-glutathionylation of eNOS, an eNOS pull-down assay was performed with a
protein G-conjugated (Novex) anti-eNOS antibody (Santa Cruz). Subsequently, immunoblotting
was performed using an anti-glutathione monoclonal antibody (ViroGen, Watertown, MA, USA).
To confirm the detection of eNOS S-glutathionylation, control samples were treated with dithiothreitol,
which removes the glutathionylation modification of eNOS.
4.8. eNOS Monomer–Dimer Ratio
The eNOS monomer–dimer ratio was determined using low-temperature SDS-PAGE (LT-PAGE)
as previously described [43]. Briefly, total proteins were incubated in 5× Laemmli buffer without
2-mercaptoethanol, and the gels and buffers were equilibrated at 4 ◦C before electrophoresis, during
which the buffer tank was placed in an ice bath to maintain the temperature of the gel. After probing
with the anti-eNOS antibody (BD Transduction Laboratory), immunoreactive bands were visualized
and analyzed with the Odyssey system (LI-COR).
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4.9. SOD Activity
To evaluate the effects of EX on the SOD activity, intracellular SOD activity (cytosolic (SOD1) and
mitochondrial (SOD2)) activity was measured using a commercially available kit (Cayman chemical).
4.10. Statistical Analysis
Data are expressed as means ± standard error of the mean (SEM). Statistical significance was
assessed using a two-way ANOVA, followed by post-hoc testing with Newman–Keuls test. Total
running distances were compared with one-way ANOVA, followed by Newman–Keuls post-hoc test.
A value of p < 0.05 was considered as statistically significant (two-tailed).
Similar to previous observations [24], we did not observe an influence of sex on the effects of TAC
and MI and/or EX on the responses of survival and LV hypertrophy or dysfunction. Consequently,
we pooled male and female mice for final analysis.
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